Clinical trial
A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11…
NCT00384189 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00384189 |
|---|---|
| Title | A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma |
| Official title | A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children With Asthma |
| Acronym | RAINBOW |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | Nycomed GmbH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Ciclesonide, Placebo, Salbutamol |
| Enrollment | 1,080 |
| Start date | Sep 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2008 |
| First posted | Oct 5, 2006 |
| Last update posted | Feb 1, 2017 |
| Countries | Bulgaria, Germany, Hungary, Poland, Romania, Russia, South Africa, Spain, Ukraine |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: